NCT04026737 2026-02-09
CVE-CART
Abramson Cancer Center at Penn Medicine
Completed
Clinical Trials
63 trialsNCT04361240 2026-02-09
Cardiotoxicity in Breast Cancer Patients Treated With Proton or Photon Radiotherapy: A RadComp Companion Study
Abramson Cancer Center at Penn Medicine
Completed
NCT07267247 2025-12-05
Cancer Therapy-Related Cardiac Dysfunction Associated With EGFR-TKIs in Advanced EGFR-mutant Non-small Cell Lung Cancer
Taichung Veterans General Hospital
Completed
NCT04598646 2025-12-03
HIMALAYAS-P
University Health Network, Toronto
Phase NA Completed
NCT03787966 2025-11-19
ATOPE
Universidad de Granada
Phase NA Completed
NCT02916316 2025-11-18
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
Fondazione Italiana Linfomi - ETS
Completed
NCT04790266 2025-11-18
CARDIOTOX
Oncology Institute of Southern Switzerland
Completed
NCT04036032 2025-10-14
Role of Aerobic Exercise to Modulate Cardiotoxicity in Long Term Cancer Survivors Exposed to Anthracycline Therapy
Connecticut Children's Medical Center
Completed
NCT06155331 2025-08-19
Evaluation of Possible Safety and Efficacy of Fenofibrate in the Prophylaxis of Doxorubicin Induced Cardiotoxicity in Breast Cancer Patients
Tanta University
Phase 2 Completed
NCT04737265 2025-07-03
NTproBNP-Guide
Abramson Cancer Center at Penn Medicine
Phase 1/2 Completed
NCT07041827 2025-06-27
CLARITY
The Netherlands Cancer Institute
Completed
NCT05786014 2025-06-12
The Effects of Two Exercise Interventions on Breast Cancer Patients Undergoing Cardiotoxic Chemotherapies
University of Virginia
Phase NA Completed
NCT04568161 2025-04-03
Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
University of Sao Paulo General Hospital
Phase NA Completed
NCT05403736 2025-02-06
CARMA
Cedars-Sinai Medical Center
Phase NA Completed
NCT04486573 2024-10-22
Cardiac Effects From Radiation Therapy by MRI
University of Colorado, Denver
Phase NA Completed
NCT03760237 2024-10-10
Cardiovascular Function in Acute Leukemia
Abramson Cancer Center at Penn Medicine
Completed
NCT03486340 2024-07-08
CATCH
Vejle Hospital
Phase NA Completed
NCT04896242 2024-04-04
Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients
Pontificia Universidad Catolica de Chile
Completed
NCT05676606 2024-03-08
Cardiotoxicity Monitoring With Single-lead Electrocardiogram
I.M. Sechenov First Moscow State Medical University
Phase NA Completed
NCT05923242 2024-01-11
ECHOS2
Washington University School of Medicine
Phase NA Completed
NCT02605512 2023-11-08
BACCARAT
Institut de Radioprotection et de Surete Nucleaire
Phase NA Completed
NCT00577798 2023-11-03
Cardiac Magnetic Resonance Imaging in Patients With Non-Hodgkin Lymphoma or Hodgkin Lymphoma Receiving Doxorubicin
University of Nebraska
Completed
NCT02881203 2023-07-27
BRAVEHeart
University of Sydney
Phase NA Completed
NCT05960214 2023-07-25
AQUA
Istanbul University
Completed
NCT05939089 2023-07-11
CASPER
Istanbul University
Completed
NCT05927246 2023-07-03
RADAF
Istanbul University
Completed
NCT04586894 2023-06-08
AMICI
Assistance Publique - Hôpitaux de Paris
Completed
NCT01719562 2023-05-19
MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum
Wake Forest University Health Sciences
Phase NA Completed
NCT03964142 2023-05-12
ONCORE
Hospital Clinico Universitario de Santiago
Phase NA Completed
NCT05130489 2023-05-12
CARTCO
University College London Hospitals
Completed
NCT03530215 2023-04-13
EROCA
Groupe Hospitalier Pitie-Salpetriere
Completed
NCT03389724 2022-11-08
Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia
Children's Cancer Hospital Egypt 57357
Phase 3 Completed
NCT02798679 2022-10-18
Cardiac Fibrosis and Risk Prediction in Cancer Treatment-Related Cardiotoxicity
University of Minnesota
Completed
NCT00436566 2022-08-05
Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Mayo Clinic
Phase 2 Completed
NCT03480087 2022-07-19
Cardiocare
A.O.U. Città della Salute e della Scienza
Completed
NCT03166813 2022-06-08
Remote Ischaemic Preconditioning in Childhood Cancer
The University of Hong Kong
Phase NA Completed
NCT03940625 2022-05-25
ANKE
Heinrich-Heine University, Duesseldorf
Phase NA Completed
NCT01212926 2022-02-09
CA2D
University Hospital, Bordeaux
Phase NA Completed
NCT01009918 2021-03-30
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
University of South Florida
Phase 2 Completed
NCT02178579 2020-09-14
PROTECT
Vanderbilt University Medical Center
Completed
NCT04434404 2020-06-16
Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy
Horus University
Phase 4 Completed
NCT02006979 2019-10-25
Acute Exercise Cardioprotection From Doxorubicin
University of British Columbia
Phase 1 Completed
NCT03235427 2019-05-21
CAROLE
Northwell Health
Completed
NCT02796365 2018-12-13
HF-PROACTIVE
Henry Ford Health System
Phase NA Completed
NCT03243604 2018-10-18
ARBITRAGE
Groupe Hospitalier Pitie-Salpetriere
Completed
NCT02423356 2018-08-21
Strain Echocardiography to Predict Cardiotoxicity in Patients Receiving Chemotherapy Containing Doxorubicin
Indiana University
Completed
NCT01904331 2018-06-15
BLOC
University Medical Center Groningen
Completed
NCT00875238 2018-02-19
PACE in BC
Vanderbilt University Medical Center
Completed
NCT01724450 2018-02-05
Ceccy
University of Sao Paulo
Phase 3 Completed
NCT02065908 2016-12-08
Circulating MicroRNA as Biomarker of Cardiotoxicity in Breast Cancer
West Pomeranian Cancer Center
Completed